BlueCross BlueShield Venture Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

InStride Healthinstride.health inSeries A · Oct 2022 · $26M

InStride provides virtual specialty care for young people ages 7 to 24 with anxiety, OCD, and related disorders, using evidence-based treatment enhanced by AI technology.

Digital HealthHealthtechMental Health

Mona Potter(Clinical Co-founder, MD)in Kathryn Boger(Clinical Co-founder, Ph.D., ABPP)in John Voith(Founder)in

Co-investors.406 Ventures Echo Health Ventures General Catalyst Mass General Brigham Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.